VMP 39696111000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Imatinib 400mg tablets
BNF code 0801050AAAAABAB
Virtual Therapeutic Moiety Imatinib
Date identifier became valid 26 May 2021
Previous product identifier 410950003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Imatinib mesilate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 414460008
Strength value numerator 400.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route suspension.oral
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Glivec 400mg tablets (Novartis Pharmaceuticals UK Ltd)
Imatinib 400mg tablets (A A H Pharmaceuticals Ltd)
Imatinib 400mg tablets (Accord-UK Ltd)
Imatinib 400mg tablets (Amarox Ltd)
Imatinib 400mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Imatinib 400mg tablets (Milpharm Ltd)
Imatinib 400mg tablets (Orion Pharma (UK) Ltd)
Imatinib 400mg tablets (Sandoz Ltd)
Imatinib 400mg tablets (Teva UK Ltd)
Imatinib 400mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Imatinib 400mg tablets 30 tablet
Imatinib 400mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback